NCT00363155View on ClinicalTrials.gov

KRN7000 in Chronic Hepatitis B

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

March 31, 2003

Study Completion Date

July 31, 2006

Conditions
Hepatitis B, Chronic
Interventions
DRUG

KRN7000

Trial Locations (1)

3015GD

Erasmus MC, University Medical Center Rotterdam, Rotterdam

Sponsors
All Listed Sponsors
lead

Foundation for Liver Research

OTHER